CONTRAST-ENCHANCED ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR HYPERPLASIA AND HEPATIC ADENOMA
https://doi.org/10.25207/1608-6228-2019-26-2-50-63
Abstract
Aim. To increase the effectiveness of the differential diagnosis of benign focal lesions of the liver using contrast-enhanced ultrasound (CEUS).
Materials and methods. A retrospective analysis of the examination results of 37 patients with morphologically confi rmed liver benign tumors was carried out. According to the morphological data, the patients were divided into two groups: 22 patients with focal nodular hyperplasia (FNH) and 15 patients with hepatocellular adenoma (HCA). All the patients underwent multiparametric ultrasound examination using CEUS.
Results. According to the obtained data, despite the nearly equal intensity of fi lling FNH and HCA with a contrast agent (96% and 80%, accordingly), FNH is characterized by an earlier contrasting (WASH IN) pattern in the arterial phase (AF), with the ‘onset of contrasting in the focus’ parameter being signifi cantly different from HCA (p<0.05). Specifi c signs of FNH included the following: the spoke-wheel pattern and an increased intensity of ultrasound contrast agent (USCA) accumulation — 96% of cases; ‘center-to-edge’ fi lling — 86% of cases. WASH-OUT is not a typical sign of FNA. A complete (100% of cases) and intensive (80% of cases) centripetal (80% of cases) fi lling is characteristic of HCA. No specifi c types of vascular pattern were observed. In 6 (40%) patients, WASH-OUT and ‘relative hyperechoic’ were detected in the portal phase.
Conclusion. CEUS is established to be an effective method of the differential diagnosis of FNH and HCA.
About the Authors
Alexey N. KatrichRussian Federation
Cand. Sci. (Med.), Head of the Ultrasound Diagnostics Department, 1 Maya str., 67, Krasnodar, 350086;
Research Assistant, Department of Surgery No. 1, Faculty of Advanced Education, Mitrofanа Sedinа str., 4, Krasnodar, 350063
Nikolai S. Ryabinin
Russian Federation
Cand. Sci. (Med.), Endoscopist, Endoscopy Department No. 2,
1 Maya str., 67, Krasnodar, 350086
Sergey V. Polshikov
Russian Federation
Doctor Radiologist, Department of Ultrasound diagnostics,
1 Maya str., 67, Krasnodar, 350086
Nikita A. Katrich
Russian Federation
Student,
Mitrofanа Sedinа str., 4, Krasnodar, 350063
References
1. Garin A. M., Bazin I. S. Ten most common malignant tumors: monograph. 2nd ed. M.: MAKSPress; 2010. 380 p.
2. Claudon M., Dietrich C. F., Choi B. I., Cosgrove D. O., Kudo M., Nolsoe C. P., Piscaglia F., Wilson S. R., Barr R. G., Chammas M. C., Chaubal N. G., Chen M. H., Clevert D. A., Correas J. M., Ding H., Forsberg F., Fowlkes J. B., Gibson R. N., Goldberg B., Lassau N., Leen E. L. S., Mattrey R. F., Moriyasu F., Solbiati L., Weskott H. P., Xu H. X. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver — update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med. Biol. 2013; 39(2): 187–210. DOI: 10.1016/j.ultrasmedbio.2012.09.002
3. Marrero J. A., Ahn J., Rajender Reddy K., American College of G. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am. J. Gastroenter.2014; 109(9): 1328–1347. DOI: 10.1038/ajg.2014.213
4. Buscarini E., Danesino C., Plauchu H., de Fazio C., Olivieri C., Brambilla G., Menozzi F., Reduzzi L., Blotta P., Gazzaniga P., Pagella F., Grosso M., Pongiglione G., Cappiello J., Zambelli A. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med. Biol. 2004; 30(9): 1089–1097. DOI: 1016/j.ultrasmedbio.2004.08.004
5. Mindikoglu A. L., Regev A., Levi J. U., Casillas J., Schiff E. R. Focal nodular hyperplasia in identical twins. Am. J. Gastroenter. 2005; 100(7): 1616–1619. DOI: 10.1111/j.1572-0241.2005.41898
6. Colombo M. EASL Clinical Practice Guidelines on the management of benign liver tumours. J. Hepatol. 2016; 65(2): 386–398. DOI: 10.1016/j.jhep.2016.04.001
7. Paradis V., Benzekri A., Dargere D., Bieche I., Laurendeau I., Vilgrain V., Belghiti J., Vidaud M., Degott C., Bedossa P. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004; 126(5): 1323–1329. DOI: 10.1053/j.gastro.2004.02.005
8. Skipenko O. G., Chardarov N. K., Shatveryan G. A., Bagmet N. N., Bedzhanyan A. L., Fedorov D. N., Khovrin V. V., Fisenko E. P. Fokal’naya nodulyarnaya giperplaziya pecheni. Khirurgiya. 2012; 6: 73–82 (In Russ.).
9. Bonder A., Afdhal N. Evaluation of liver lesions. J. Clin. Liver Dis. 2012; 16(2): 271–283. DOI: 10.1016/j. cld.2012.03.001
10. Luk’yanchenko A. B., Medvedeva B. M. The current approaches to the diagnosis of hepatocellular adenomas (literature review аnd clinical cases). Meditsinskaya Vizualizatsiya. 2013; 1: 33–43 (In Russ., English abstract).
11. Agnello F., Ronot M., Valla D. C., Sinkus R., Van Beers B. E., Vilgrain V. High b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012; 262(2): 511–519. DOI: 10.1148/radiol.11110922
12. Grazioli L., Federle M. P., Brancatelli G., Ichikawa T., Olivetti L., Blachar A. Hepatic Adenomas: Imaging and Pathologic Findings. RadioGraphics. 2001; 21(4): 877–892. DOI: 10.1148/radiographics.21.4.g01jl04877
13. Giannitrapani L., Soresi M., La Spada E., Cervello M., D’Alessandro N., Montalto G. Sex hormones and risk of liver tumor. J. Ann. NY Acad. Sci. 2006; 1089(1): 228–236. DOI: 10.1196/annals.1386.044
14. Ribeiro Junior M. A., Chaib E., Saad W. A., D’Albuquerque L. A., Cecconello I. Surgical management of spontaneous ruptured hepatocellular adenoma. Clinics. 2009; 64(8): 775–779. DOI: 10.1590/s1807-59322009000800011
15. Bieze M., Phoa S. S., Verheij J., van Lienden K. P., van Gulik T. M. Risk factors for bleeding in hepatocellular adenoma. Br. J. Surg. 2014; 101(7): 847–855. DOI: 10.1002/bjs.9493
16. Reeves H., Manas D. M., Lochaan R. Liver tumors — epidemiology, diagnosis, prevention and treatent. InTech, Chapters published April 10, 2013 under CC BY 3.0. 184 p. DOI: 10.5772/56514
17. Farges O., Ferreira N., Dokmak S., Belghiti J., Bedossa P., Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. J. Gut. 2011; 60(1): 85–89. DOI: 10.1136/gut.2010.222109
18. Foster J. H., Berman M. M. The malignant transformation of liver cell adenomas. J. Arch. Surg. 1994; 129(7): 712–717. DOI: 10.1001/archsurg.1994.01420310044007
19. Trufanov G. E., Bagnenko S. S., Rud’ S. D. Luchevaya diagnostika zabolevanii pecheni. Saint-Peterburg: ELBI-SPb.; 2011. 415 р. (In Russ.). 20. Colombo M. EASL Clinical Practice Guidelines on the management of benign liver tumours. J. Hepatol. 2016; 65(2): 386–398. DOI: 10.1016/j.jhep.2016.04.001
20. Westwood M., Joore M., Grutters J., Redekop K., Armstrong N., Lee K., Gloy V., Raatz H., Misso K., Severens J., Kleijnen J. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafl uoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. J. Health Tech. Ass. 2013; 17(16): 1–243. DOI: 10.3310/hta17160
21. Sonov’yu. Nauchnaya monografi ya. Dinamicheskoe kontrastnoe usilenie v rezhime real’nogo vremeni. Moscow: Bracco; 2014. 45 р. (In Russ.). 23. Weskott H.-P. Сontrast sonography. Bremen: UNI–MED; 2014. 284 р. (In Russ.).
22. Katabathina V. S., Menias C. O., Shanbhogue A. K., Jagirdar J., Paspulati R. M., Prasad S. R. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011; 31(6): 1529–1543. DOI: 10.1148/rg.316115527
23. Nault J. C., Bioulac-Sage P., Zucman-Rossi J. Hepatocellular benign tumors-from molecular classifi cation to personalized clinical care. Gastroenterology. 2013; 144(5): 888–902. DOI: 10.1053/j.gastro.2013.02.032
24. Pilati C., Letouze E., Nault J. C., Imbeaud S., Boulai A., Calderaro J., Poussin K., Franconi A., Couchy G., Morcrette G., Mallet M., Taouji S., Balabaud C., Terris B., Canal F., Paradis V., Scoazec J. Y., de Muret A., Guettier C., Bioulac-Sage P., Chevet E., Calvo F., Zucman-Rossi J. Genomic profi ling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. J. Cancer Cell. 2014; 25(4): 428–441. DOI: 10.1016/j.ccr.2014.03.005
25. Zucman-Rossi J., Jeannot E., Nhieu J. T., Scoazec J. Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E. S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classifi cation and relationship with HCC. Hepatology. 2006; 43(3): 515–524. DOI: 10.1002/hep.21068
26. Yen Y. H., Wang J. H., Lu S. N., Chen T. Y., Changchien C. S., Chen C. H., Hung C. H., Lee C. M. Contrast-enhanced ultra-sonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur. J. Radiol. 2006; 60(3): 439–444. DOI: 10.1016/j.ejrad.2006.06.007
27. Hussain S. M., van den Bos I. C., Dwarkasing R. S., Kuiper J. W., Hollander J. Hepatocellular adenoma: Findings at state-of-the-Art MR Imaging, US, CT, and Pathologic Analysis. J. Eur. Radiol. 2006; 16(9): 1873–1886. DOI: 10.1007/s00330-006-0292-4
28. Dietrich C. F., Schuessler G., Trojan J., Fellbaum C., Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br. J. Radiol. 2005; 78(932): 704–707. DOI: 10.1259/bjr/88181612
Review
For citations:
Katrich A.N., Ryabinin N.S., Polshikov S.V., Katrich N.A. CONTRAST-ENCHANCED ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR HYPERPLASIA AND HEPATIC ADENOMA. Kuban Scientific Medical Bulletin. 2019;26(2):50-63. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-2-50-63